A PYMNTS Company

Vertical Health-Care Mergers Still in DOJ Crosshairs, Despite ‘Huge’ AT&T-Time Warner Loss

By  |  July 12, 2018

Posted by Health Care Blog

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Vertical Health-Care Mergers Still in DOJ Crosshairs, Despite ‘Huge’ AT&T-Time Warner Loss

    By Meg McEvoy

    Judge Richard Leon’s opinion in the AT&T-Time Warner vertical merger case will likely be evaluated by antitrust attorneys for years, but what do lawyers think about it now?

    My story after the decision talked about how it is likely to impact vertical health-care deals like CVS’s acquisition of Aetna and Cigna’s acquisition of Express Scripts. Essentially, the article explained that these transactions won’t get a free pass based on the court’s analysis of AT&T-Time Warner. Health-care and video content are very different markets. And AT&T-Time Warner was a “pure vertical” deal, with no elements of the merged businesses creating a concentration in an existing market. That, however, isn’t the case with the health-care mergers.

    Still, there will be significant hurdles for regulators should they seek to bring another merger case in the health-care space based primarily on theories of harm caused by vertical acquisitions.

    I interviewed Douglas C. Ross, a partner with Davis Wright Tremaine in Seattle about the AT&T-Time Warner opinion.

    Continue reading…